7 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 10 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 7, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Brief Psychotic Disorder: new trials by email Literature Review of Brief Psychotic Disorder trials Research Report on Brief Psychotic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis FEEL GOOD, Treatment as Usual (TAU) - Delusional Disorder, Brief Psychotic Disorder | Not applicable | Recruiting | Stephanie Mehl | 252 | 2026-05-27 | 2026-09-22 |
| Accelerated rTMS for Psychomotor Slowing cTBS (continuous Theta Burst Stimulation) - Schizophrenia; Psychosis, Schizophrenia and Related Disorders | Not applicable | Terminated | University of Bern | 25 | 2023-09-22 | 2024-09-25 |
| Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders Cognitive Remediation (REHACOP), Metacognitive Training (MCT) - Schizophrenia, Schizophreniform Disorders | Not applicable | Unknown | Universitat Autonoma de Barcelona | 160 | 2022-09-01 | 2024-05-23 |
| Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement Rituximab - Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior | Phase 2 | Enrolling by invitation | Uppsala University Hospital | 40 | 2022-05-01 | 2024-11-19 |
| Feasibility of a Novel Process-based Treatment for Patients With Psychosis Metacognitive and Defusion Training - Schizophrenia, Schizotypal Disorder | Not applicable | Completed | Max-Planck-Institute of Psychiatry | 37 | 2021-05-10 | 2023-10-23 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial PACE-Life, Exercise Intervention - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | University of North Carolina, Chapel Hill | 50 | 2019-12-20 | 2022-09-22 |
| Overcoming Psychomotor Slowing in Psychosis (OCoPS-P) 1 Hz rTMS, iTBS, Placebo - Schizophrenia and Related Disorders, Schizophrenia | Not applicable | Completed | University of Bern | 103 | 2019-03-25 | 2023-02-14 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Exercise Intervention- PACE-Life - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | University of North Carolina, Chapel Hill | 17 | 2018-12-06 | 2020-09-21 |
| Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution MCT+ - Brief Psychotic Disorder, Psychosis; Episode | Not applicable | Completed | Fundació Sant Joan de Déu | 70 | 2015-01-01 | 2020-06-12 |
| Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia CBT-E, Treatment as Usual - Schizophrenia, Delusional Disorder | Not applicable | Completed | Philipps University Marburg | 64 | 2014-01-01 | 2020-03-04 |
| An Integrated Program for the Treatment of First Episode of Psychosis Integrated Treatment, Community Care - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | Northwell Health | 404 | 2010-07-01 | 2021-10-26 |
Psychotic Disorders (11) · Schizophrenia (10) · Schizophrenia, Paranoid (5) · Motor Activity (3) · Emotional Regulation (2) · Mental Disorders (2) · Psychomotor Disorders (2) · Bipolar Disorder (1) · Compulsive Behavior (1) · Depressive Disorder, Major (1) · Mania (1) · Obsessive-Compulsive Disorder (1) · Recurrence (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Schizotypal Personality Disorder (1)
Schizophrenia Spectrum and Other Psychotic Disorders (10) · Mental Disorders (9) · Behavior (6) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Self-Control (2) · Social Behavior (2) · Anxiety Disorders (1) · Bipolar and Related Disorders (1) · Depressive Disorder (1) · Disease Attributes (1) · Impulsive Behavior (1)
Therapeutics (2) · Cognitive Remediation (1) · Rituximab (1) · Transcranial Magnetic Stimulation (1)
University of Bern (2) · University of North Carolina, Chapel Hill (2) · Fundació Sant Joan de Déu (1) · Max-Planck-Institute of Psychiatry (1) · Northwell Health (1) · Philipps University Marburg (1) · Stephanie Mehl (1) · Universitat Autonoma de Barcelona (1) · Uppsala University Hospital (1)
Germany (3) · United States (3) · Switzerland (2) · Spain (1) · Sweden (1)
Ana Barajas Velez (1) · Andreas Bechdolf, Prof. Dr. (1) · David L Penn, PhD (1) · David Penn, PhD (1) · Janet L Cunningham, MD PhD (1) · Johannes M Kopf-Beck, PhD (1) · John Kane, MD (1) · Sebastian Walther, MD (1) · Sebastian Walther, Prof. Dr. med (1) · Stephanie Mehl, Ph. D. (1) · Stephanie Mehl, Prof. Dr. (1) · Susanne Lucae, MD, Prof. (1) · Tania M. Lincoln (1) · Tilo Kircher (1) · Winfried Rief (1)
PMID 25727536, PMID 25830446, PMID 26481174, PMID 28427286, PMID 28945118, PMID 29444349, PMID 30139553, PMID 31026764, PMID 31084291, PMID 32052566, PMID 33493778, PMID 35026597, PMID 36623822, PMID 37657279, PMID 38416468, PMID 40643782, PMID 41920015, PMID 42531158, PMID 42768802
R34MH111852 (2), 2018 (1), 2019 (1)